Female‐Versus‐Male Alloreactivity as a Model for Minor Histocompatibility Antigens in Hematopoietic Stem Cell Transplantation
暂无分享,去创建一个
R. Brand | A. Gratwohl | H. Baldomero | D. Niederwieser | J. Passweg | V. Rocha | T. D. de Witte | M. Stern | A. Sureda
[1] G. Gahrton. Risk assessment in haematopoietic stem cell transplantation: impact of donor-recipient sex combination in allogeneic transplantation. , 2007, Best practice & research. Clinical haematology.
[2] J. Falkenburg,et al. Minor histocompatibility antigen DDX3Y induces HLA-DQ5-restricted T cell responses with limited TCR-Vbeta usage both in vivo and in vitro. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[3] A. Gratwohl,et al. Influence of Donor/Recipient Sex Matching on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia , 2006, Transplantation.
[4] N. Kröger,et al. The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants , 2005, Bone Marrow Transplantation.
[5] Catherine J. Wu,et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. , 2004, Blood.
[6] E. Warren,et al. A Novel HLA-A*3303-Restricted Minor Histocompatibility Antigen Encoded by an Unconventional Open Reading Frame of Human TMSB4Y Gene1 , 2004, The Journal of Immunology.
[7] F. Appelbaum,et al. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. , 2004, Blood.
[8] J. Falkenburg,et al. Minor histocompatibility antigens in human stem cell transplantation. , 2003, Experimental hematology.
[9] J. Drijfhout,et al. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. , 2002, Blood.
[10] H. V. van Houwelingen,et al. Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. , 2001, The hematology journal : the official journal of the European Haematology Association.
[11] J. Falkenburg,et al. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. , 2000, Blood.
[12] C. Disteche,et al. The Human UTY Gene Encodes a Novel HLA-B8-Restricted H-Y Antigen1 , 2000, The Journal of Immunology.
[13] J. Falkenburg,et al. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. , 2000, Blood.
[14] J. Shabanowitz,et al. Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. , 1999, Journal of immunology.
[15] N. Rufer,et al. HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation. , 1998, Transplantation.
[16] R. Hammer,et al. Novel HY peptide antigens presented by HLA-B27. , 1997, Journal of immunology.
[17] A. Agulnik,et al. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. , 1997, Immunity.
[18] M. Pepe,et al. Previous donor pregnancy as a risk factor for acute graft‐versus‐host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation , 1990, British journal of haematology.
[19] E. Goulmy,et al. ALLOIMMUNITY TO HUMAN H-Y , 1976, The Lancet.
[20] R. Nelson,et al. CYTOMEGALOVIRUS IN NON-B POST-TRANSFUSION HEPATITIS , 1974 .